Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders.

Prokai L, Nguyen V, Szarka S, Garg P, Sabnis G, Bimonte-Nelson HA, McLaughlin KJ, Talboom JS, Conrad CD, Shughrue PJ, Gould TD, Brodie A, Merchenthaler I, Koulen P, Prokai-Tatrai K.

Sci Transl Med. 2015 Jul 22;7(297):297ra113. doi: 10.1126/scitranslmed.aab1290.

2.

Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.

Archer DF, Pinkerton JV, Guico-Pabia CJ, Hwang E, Cheng RF; Study 3353 Investigators..

Menopause. 2013 Jan;20(1):47-56. doi: 10.1097/gme.0b013e3182775fe9.

PMID:
23266840
3.

Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.

Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, Rosal MC, Wenger NK, Wassertheil-Smoller S.

Arch Intern Med. 2009 Dec 14;169(22):2128-39. doi: 10.1001/archinternmed.2009.436.

PMID:
20008698
4.

Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.

Johansen OE, Qvigstad E.

Adv Ther. 2008 Jun;25(6):525-51. doi: 10.1007/s12325-008-0070-6. Review.

PMID:
18568306
5.

Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.

de Simone G, Romano C, De Caprio C, Contaldo F, Salanitri T, di Luzio Paparatti U, Pasanisi F.

Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):24-30.

PMID:
15871847
6.

Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).

Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J.

Arch Intern Med. 2004 Feb 9;164(3):289-98.

PMID:
14769624
Items per page

Supplemental Content

Loading ...
Support Center